These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 36281290)
1. Construction and Verification of a Novel Pyroptosis-Related lncRNA Signature Associated with Immune Landscape in Gliomas. Feng X; Chen Y; Liu X; Zhong Z; Liu Y J Oncol; 2022; 2022():7043431. PubMed ID: 36281290 [TBL] [Abstract][Full Text] [Related]
2. A Novel Prognostic Pyroptosis-Related Gene Signature Correlates to Oxidative Stress and Immune-Related Features in Gliomas. Zeng S; Li W; Ouyang H; Xie Y; Feng X; Huang L Oxid Med Cell Longev; 2023; 2023():4256116. PubMed ID: 36778205 [TBL] [Abstract][Full Text] [Related]
3. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
4. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration. Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094 [TBL] [Abstract][Full Text] [Related]
5. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma. Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808 [No Abstract] [Full Text] [Related]
6. Development and Validation of a Robust Pyroptosis-Related Signature for Predicting Prognosis and Immune Status in Patients with Colon Cancer. Zhuang Z; Cai H; Lin H; Guan B; Wu Y; Zhang Y; Liu X; Zhuang J; Guan G J Oncol; 2021; 2021():5818512. PubMed ID: 34840571 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration. Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373 [TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma. Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J Front Genet; 2022; 13():838624. PubMed ID: 35928454 [TBL] [Abstract][Full Text] [Related]
9. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients. He Y; Ye Y; Tian W; Qiu H Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662 [No Abstract] [Full Text] [Related]
10. Construction of a Pyroptosis-Related Signature for Prognostic Prediction and Characterization of Immune Microenvironment in Acute Myelogenous Leukemia. Liu S; Luo D; Luo J; Liang H; Zhi Y; Wang D; Xu N Int J Gen Med; 2022; 15():2913-2927. PubMed ID: 35308573 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas. Sun P; Wang X; Zhong J; Yu D; Xuan H; Xu T; Song D; Yang C; Wang P; Liu Y; Meng X; Cai J Front Genet; 2023; 14():1087563. PubMed ID: 36861130 [No Abstract] [Full Text] [Related]
12. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients. Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460 [TBL] [Abstract][Full Text] [Related]
14. A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma. Xia F; Yan Y; Shen C Front Cell Dev Biol; 2021; 9():811734. PubMed ID: 34966747 [TBL] [Abstract][Full Text] [Related]
15. Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer. Cao X; Zhang Q; Zhu Y; Huo X; Bao J; Su M Front Oncol; 2022; 12():780950. PubMed ID: 35280739 [TBL] [Abstract][Full Text] [Related]
16. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma. Tan Y; Lu L; Liang X; Chen Y World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978 [TBL] [Abstract][Full Text] [Related]
17. Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients. Wu J; Lu L; Wang C; Jiang F J Oncol; 2022; 2022():8164756. PubMed ID: 35646114 [TBL] [Abstract][Full Text] [Related]
18. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977 [No Abstract] [Full Text] [Related]
19. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients. Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B Front Genet; 2022; 13():966896. PubMed ID: 36186456 [No Abstract] [Full Text] [Related]
20. Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature. Lu L; Zhang P; Cao X; Guan M J Oncol; 2022; 2022():1539659. PubMed ID: 35432539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]